Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ...

The pharmaceutical industry operates within one of the most highly regulated environments globally, where precision, ...

2025 promises to be a tumultuous year for the American healthcare and pharma sector. Increased scrutiny on pricing and the ...

The pharmaceutical industry’s biggest investment conference drew protesters in San Francisco Monday with signs reading “delay ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to ...

The biopharmaceutical industry is cautiously optimistic about reversing last year's slump in investor returns. The sector faces uncertainties related to changes in US government policies, including ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of ...